InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: antihama post# 2460

Friday, 01/18/2019 9:55:24 AM

Friday, January 18, 2019 9:55:24 AM

Post# of 3283
Well said Antihama.

I would like to see them sell their CASI stock as soon as they can. Makes no sense to me that a small biotech holds stock in another small biotech, especially since we are now disinterested in their drugs.

I would like to see a filing for Rolontis approval in Europe and a follow on co-licensing deal for Europe.

I still think JT may be making a mistake with Qapzola. Looks like they are not making any efforts to push the recruiting through. I believe Qapzola is a $100M+ product and they should get it approved and co-license it. This is a bird in hand.

I want them to find another late stage portfolio complimenting drug, but think they need to get Rolontis selling or the PPS up substantially before they can afford a new late stage drug. Perhaps in late 2020.

SPPI is now positioned to go it alone. We don't need to accept any low ball BO.

Fun times and a new beginning.